Point of Care Testing Market Surpass $38.40 Billion By 2026 | CAGR 21.7

Author: Acumen Research and Consulting

Worldwide point of care testing market is worth at over USD 21.7 billion in 2018 and is likely to rise up to USD 38.40 billion by 2026.

Increment in number of individuals experiencing infectious sicknesses and chronic conditions in developing countries, for example, China and India will support the demand and adoption rate of point of care testing molecular diagnostic services. As per the statistics published by a UK-based association, Avert, there were around 88,000 new incidence and almost 69,000 deaths because of HIV disease in India in the year 2017. Subsequently, developing commonness and consciousness of infectious illnesses will animate the development of point of care testing devices market later on.

Download Report Sample Pages For Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1136 

Recent technological advancements in point of care testing devices will increase the business development in the forthcoming years. Utilization of a few unique combinations, for example, bio-sensing stages with cell phone coordinated electronic perusers will give exact nearby and on-time diagnostics. With healthcare frameworks concentrating more on populace health, accuracy medication and the executives of perpetual ailment, effect of point of care testing keeps on developing, and a few noticeable point of care testing demonstrative patterns have risen in the most recent decade, increasing the market development.

Glucose monitoring devices market held most of market share in the year 2018 and was esteemed around USD 5,309.2 million. Developing predominance of diabetes in developed just as creating countries will be the real driving element for segmental development. As per the International Diabetes Federation (IDF) and Diabetes Atlas, in excess of 415 million individuals, matured between 20-79 years, had diabetes in 2015 and this number is assessed to reach to 642 million by 2040. Change in way of life, dietary propensities, expanded smoking and liquor utilization and other ecological components are probably going to upsurge this number, filling the business development in the inevitable years.

Tumor/cancer growth marker testing products market is assessed to develop at 7.9% within a reasonable time-frame. Increment in predominance of cancer over the globe will spur the demand and reception rate of disease or tumor marker testing products, boosting the business development. As per the insights distributed the by American Cancer Society, there were evaluated 1.7 million new cancer cases analyzed and 600,000 disease deaths in the Unites States in 2018. Thus, developing number of individuals experiencing cancer will drive the development of disease marker testing products market in the inevitable years.

VIEW DETAIL REPORT WITH COMPLETE TOC@ https://www.acumenresearchandconsulting.com/point-of-care-testing-market 

The global point of care testing market is segmented into product,technology,prescription, application,end-user, and region.On the basis  product, the global point of care testing market is segmented into Glucose monitoring (Strips, Meters, Lancets), Cardiometabolic testing products (Cardiac marker testing products, Blood Gas/Electrolytes testing products, HBA1C testing products), Infectious disease testing products (Influenza testing products, HIV testing products, Hepatitis C testing products, Sexually Transmitted Disease (STD) testing products, Healthcare-Associated Infection (HAI) testing products, Respiratory infection testing products, Tropical disease testing products, Other infectious diseases testing products), Coagulation testing products (PT/INR testing products, Activated Clotting Time (ACT/APTT) testing products), Pregnancy and fertility testing products, (Pregnancy testing products, Fertility testing products), Tumor/Cancer marker testing products, Urinalysis testing products, Cholesterol testing products, Hematology testing products, Drug-of-Abuse (DoA) testing products, Fecal occult testing products, and Other products. On the basis technology, the global point of care testing market is segmented into Lateral flow assays, Dipsticks, Microfluidics, Molecular diagnostics, Immunoassays, Agglutination assays, Flow-Through, Solid phase, and Biosensors. On the basis prescription, the global point of care testing market is segmented into OTC testing and prescription-based testing. On the basis application, the global point of care testing market is segmented into cardio metabolic testing, infectious disease testing, nephrology testing, drug-of-abuse (DOA) testing, blood glucose testing, pregnancy testing, cancer biomarker testing, and other applications. On the basis end-user, the global point of care testing market is segmented into hospitals, diagnostic centers, research laboratories, home-care settings, and other end-uses. On the basis of region the global point of care testing market is bifurcated into Europe, Latin America, North America, Middle East & Africa, and Asia Pacific.

Some of the note worthy companies linked with the global point of care testing market are Abaxis, Abbott,Siemens AG,F. Hoffmann-La Roche Ltd., and Johnson and Johnson.

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1136 

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report - https://www.acumenresearchandconsulting.com/buy-now/0/1136 

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157